Streetbeat News

Stock Prices

CYRX

UBS analyst John Sourbeer has downgraded CryoPort (NASDAQ:CYRX) from Buy to Neutral and lowered the price target from $28 to $17.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 1:34 pm

AAPL

AMZN

CMCSA

NFLX

PARA

WBD

NBCUniversal's streaming platform, Peacock, is set to increase its subscription prices for the first time since its debut in 2020. The price hike, effective from August 17, comes as the platform's subscriber figures continue to grow, reaching nearly 22 million in the first three months of 2023. The price increase will allow NBCUniversal to invest in strong programming and remain competitive. Other major streaming services like Paramount Global's Paramount+, Warner Bros Discovery's HBO Max, Disney+, Netflix, Apple TV+, and Amazon Prime Video have also raised prices.

Portfolio Pulse from Vandana Singh

July 18, 2023 | 1:31 pm

ABBV

AbbVie's (NYSE:ABBV) short percent of float has fallen 7.81% since its last report, with 10.36 million shares sold short, which is 0.59% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. AbbVie's short interest as a percentage of float is lower than its peer group average of 3.62%.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:30 pm

CMCSA

Comcast's (NYSE:CMCSA) short percent of float has fallen 11.7% since its last report, with 34.27 million shares sold short, which is 0.83% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, Comcast has less short interest as a percentage of float, with an average of 13.65%.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:30 pm

XOM

Exxon Mobil's (NYSE:XOM) short percent of float has fallen 23.53% since its last report, indicating a decrease in bearish sentiment. The company has 26.41 million shares sold short, which is 0.65% of all regular shares available for trading. Compared to its peers, Exxon Mobil has less short interest as a percentage of float, which is 1.63% on average.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:30 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has increased its market share in global smartphone shipments to 17% in Q2 2023, up from 16% a year ago, despite a global slowdown in smartphone shipments. Apple's shipments fell by only 2%, compared to an 8% decline in global smartphone shipments. Apple's resilience is attributed to the premium nature of iPhones, which are relatively immune to the slowdown. Apple's gains were particularly notable in markets like India, where its shipments registered a 50% year-on-year growth.

Portfolio Pulse from Rounak Jain

July 18, 2023 | 1:29 pm

FREY

Goldman Sachs analyst Philipp Konig has downgraded FREYR Battery (NYSE:FREY) from Buy to Neutral and lowered the price target from $14 to $10.

Portfolio Pulse from richadhand@benzinga.com

July 18, 2023 | 1:28 pm

CMG

Chipotle Mexican Grill Inc (NYSE:CMG) shares are trading higher after the company announced plans to open locations in the Middle East next year. The company has signed a development agreement with international franchise retail operator Alshaya Group to open restaurants in Dubai and Kuwait. Multiple analysts have also given positive updates this week, with TD Cowen and Oppenheimer maintaining an Outperform rating and raising their price targets.

Portfolio Pulse from Adam Eckert

July 18, 2023 | 1:28 pm

SCHW

Charles Schwab Corp reported a Q2 net revenues decline of 9% Y/Y to $4.66 billion, beating the consensus of $4.61 billion. Asset management and administration fees increased 12% Y/Y to $1.17 billion, while trading revenue declined 9% Y/Y to $803 million. Adjusted net income fell 25% Y/Y to $1.49 billion in Q2. Adjusted EPS stood at $0.75, down 23% Y/Y, exceeding the consensus of $0.71. SCHW shares are trading higher by 8.4% at $63.56 premarket on the last check Tuesday.

Portfolio Pulse from Lekha Gupta

July 18, 2023 | 1:28 pm

NLTX

Neoleukin Therapeutics Inc (NASDAQ:NLTX) is set to merge with privately-held Neurogene Inc in an all-stock transaction. The combined company will focus on advancing Neurogene's pipeline of genetic medicines and will operate under the name Neurogene Inc, trading under the ticker symbol 'NGNE'. The merger is expected to close in Q4 2023, with pre-merger Neoleukin stockholders owning approximately 16% of the combined company. NLTX shares are down 6.19% in premarket trading.

Portfolio Pulse from Vandana Singh

July 18, 2023 | 1:26 pm